We have recently characterized the existence of a functional connection between NCX1 activity and metabolic substrates utilization, with particular reference to glutamate, in different in vitro pathological settings, such as cardiac and neuronal ischemia, PD and AD [36,40]. The gene discussed is SLC8A1; the disease is Parkinson disease.